FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024

Nov 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-11-13

Reporting Person: Sayad Pierre Sargis (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-13	Stock Options	$4.23	A	150000	Acquired	2034-11-13	Common Shares (150000)	Direct

Footnotes

F1: On November 13, 2024, Pierre Sayad was granted incentive stock options to purchase 150,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F2: One-third of the shares subject to this option may be exercised as of November 13, 2025 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date until all shares have vested.